Eukaryotic translation initiation factor < Eular < Eular abstracts

Facettes : Author.f AffPays.f AffRegion.f AffVille.f AffOrg.f KwdFr.f Mesh.f MeshFr.f Teeft.f

List of bibliographic references indexed by Eular

Number of relevant bibliographic references: 60.
[0-20] [0 - 20][0 - 50][20-40]

Ident.	Authors (with country if any)	Title
002849 (2013)	Muriel Elhai [France] ; Marine Meunier [France] ; Marco Matucci-Cerinic [Italie] ; Britta Maurer [Suisse] ; Gabriela Riemekasten [Allemagne] ; Tifenn Leturcq [France] ; Raffaele Pellerito [Italie] ; Carlos Alberto Von Mühlen [Brésil] ; Alessandra Vacca [Italie] ; Paolo Airo [Italie] ; Francesca Bartoli [Italie] ; Ginevra Fiori [Italie] ; Maria Bokarewa [Suède] ; Valeria Riccieri [Italie] ; Mike Becker [Allemagne] ; Jérôme Avouac [France] ; Ulf Müller-Ladner [Allemagne] ; Oliver Distler [Suisse] ; Yannick Allanore [France]	Outcomes of patients with systemic sclerosis-associated polyarthritis and myopathy treated with tocilizumab or abatacept: a EUSTAR observational study
002874 (2013)	Josef S. Smolen [Autriche] ; Monika M. Schoels [Autriche] ; Norihiro Nishimoto [Japon] ; Ferdinand C. Breedveld [Pays-Bas] ; Gerd R. Burmester [Allemagne] ; Maxime Dougados [France] ; Paul Emery [Royaume-Uni] ; Gianfranco Ferraccioli [Italie] ; Cem Gabay [Suisse] ; Allan Gibofsky [États-Unis] ; Juan Jesus Gomez-Reino [Espagne] ; Graeme Jones [Australie] ; Tore K. Kvien [Norvège] ; Miho Murakami [Japon] ; Neil Betteridge [Royaume-Uni] ; Clifton O. Bingham [États-Unis] ; Vivian Bykerk [Suisse] ; Ernest H. Choy [Royaume-Uni] ; Bernard Combe [France] ; Maurizio Cutolo [Italie] ; Winfried Graninger [Autriche] ; Angel Lanas [Espagne] ; Emilio Martin-Mola [Espagne] ; Carlomaurizio Montecucco [Italie] ; Mikkel Ostergaard [Danemark] ; Karel Pavelka [République tchèque] ; Andrea Rubbert-Roth [Allemagne] ; Naveed Sattar [Royaume-Uni] ; Marieke Scholte-Voshaar [Suisse] ; Yoshiya Tanaka [Japon] ; Michael Trauner [Autriche] ; Gabriele Valentini [Italie] ; Kevin L. Winthrop [États-Unis] ; Maarten De Wit [Pays-Bas] ; Désirée Van Der Heijde [Pays-Bas]	Consensus statement on blocking the effects of interleukin-6 and in particular by interleukin-6 receptor inhibition in rheumatoid arthritis and other inflammatory conditions
002909 (2013)	T. Harrison ; L. Martin ; C. Barnabe ; K. Fyie [Canada]	THU0599 From Bad to Worse? The Impact of Switching Biologic Agents Multiple Times on Work Productivity and Health-Related Quality of Life for Patients with RA.
002910 (2013)	Y. Van Eijk-Hustings [Pays-Bas] ; B. Buss [Allemagne] ; F. Fayet [France] ; A. Moretti [Italie] ; M. Ndosi [Royaume-Uni] ; S. Ryan [Royaume-Uni] ; C. Savel [France] ; M. Scholte-Voshaar [Pays-Bas] ; J. De La Torre-Aboki [Espagne] ; A. Van Tubergen [Pays-Bas]	THU0598 Dissemination and Evaluation of the Eular Recommendations for the Role of the Nurse in the Management of Chronic Inflammatory Arthritis
002911 (2013)	H. Zwikker [Pays-Bas] ; C. Van Den Ende [Pays-Bas] ; S. Van Dulmen [Pays-Bas] ; W. Van Lankveld [Pays-Bas] ; A. Den Broeder [Pays-Bas] ; F. Van Den Hoogen [Pays-Bas] ; B. Van De Mosselaar [Pays-Bas] ; B. Van Den Bemt [Pays-Bas]	THU0597 Effectiveness of a Group-Based Intervention to Improve Medication Beliefs and Adherence in Non-Adherent Patients with Rheumatoid Arthritis: A Randomized Controlled Trial
002912 (2013)	P. Cornell [Royaume-Uni] ; S. Westlake [Royaume-Uni] ; P. Thompson [Royaume-Uni] ; S. Richards [Royaume-Uni]	THU0596 Tight Control with Regular Review for Rheumatoid Arthritis in a DGH - Reduces the Use of Biologic Therapy According to Nice Guidelines even if Moderate Disease Activity was Treated
002913 (2013)	R. Bakker [Pays-Bas] ; A. V. Ede [Pays-Bas] ; F. Lamers-Karnebeek [Pays-Bas] ; I. Meek [Pays-Bas] ; T. Jansen [Pays-Bas]	THU0577 Protocol-Bvased Pharmacotherapy in Gout Delivered by Specialised Health Care Professional Under Supervision of a Rheumathologist is Similar but not Significantly Superior to Care as Usual
002A25 (2013)	Y.-M. Pers [France] ; C. Fortunet ; E. Constant ; J. Lambert [France] ; A. Mazouyes [France] ; M. Valnet [France] ; H. Marotte ; P. Gaudin [France] ; D. Wendling [France] ; J.-F. Maillefert ; C. Jorgensen [France]	THU0126 Multicenter retrospective study: Response to tocilizumab in clinical practice is not influenced by the number of previous biotherapy or by association with a DMARD
002A26 (2013)	T. Matsubara ; H. Inoue ; M. Iwahashi ; A. Yamazaki ; T. Takeuchi [Japon]	THU0125 A multi-center, double-dummy, double-blind study of subcutaneous (SC) abatacept (ABA) compared with intraveneous (IV) ABA in japanese rheumatoid arthritis patients with inadequate response to methotrexate
002A27 (2013)	T. Kojima ; K. Funahashi ; N. Takahashi ; D. Kato ; H. Matsubara ; Y. Hattori ; Y. Yabe [Japon] ; N. Ishiguro	THU0124 Importance of monitoring of C-reactive protein level to predict achievement of better clinical outcome during treatment with tocilizumab in patients with rheumatoid arthritis
002A35 (2013)	M. Benucci ; G. Saviola ; M. Manfredi [Italie] ; F. Atzeni [Royaume-Uni] ; P. Sarzi Puttini [Italie]	THU0113 Predictive factors of response to rituximab therapy modify the accelerated atherosclerosis in patients with rheumatoid arthritis
002A36 (2013)	M. Skwarek [Allemagne] ; B. Heschel [Allemagne] ; M. Winzer [Allemagne] ; M. Aringer [Allemagne]	THU0112 Effects of inflammatory activity and therapeutic interleukin-6 receptor (IL-6R) blockade on IL-6R alpha expression and STAT3 phosphorylation in rheumatoid arthritis (RA)
002A37 (2013)	M. Genovese [États-Unis] ; H. Kellner [Allemagne] ; P. Durez [Belgique] ; C. E. Codding [États-Unis] ; G. Ligozio [États-Unis] ; H. B. Richards [Suisse] ; C. Escrig [Suisse] ; S. Mpofu [Suisse]	THU0111 Secukinumab treatment improves ACR50, HAQ-DI and eular remission rates in patients with rheumatoid arthritis
002A41 (2013)	Y. Yonemoto ; K. Okamura ; K. Takeuchi ; M. Matsushita [Japon] ; T. Kaneko ; T. Kobayashi ; T. Aramaki [Japon] ; K. Takagishi	THU0094 Direct comparison of four biological agents in bio-naïve rheumatoid arthritis patients
002A42 (2013)	M. Dougados [France] ; K. Kissel [Suisse] ; P. G. Conaghan [Royaume-Uni] ; E. Martin-Mola [Espagne] ; G. Schett [Allemagne] ; H. Amital [Israël] ; R. M. Xavier [Brésil] ; O. Troum [États-Unis] ; C. Bernasconi [Suisse] ; T. W. J. Huizinga [Pays-Bas]	THU0093 Clinical, radiographic, and immunogenic effects after 1 year of tocilizumab (TCZ)-based treatment strategy with and without methotrexate (MTX) in RA: The act-ray study
002A46 (2013)	S. Das [Royaume-Uni] ; S. Horton [Royaume-Uni] ; E. Vital ; D. Bryer [Royaume-Uni] ; P. Emery [Royaume-Uni] ; M. Buch [Royaume-Uni]	THU0089 Response to abatacept and tocilizumab in patients who had failed rituximab– initial single centre experience
002A47 (2013)	G. Arumugakani [Royaume-Uni] ; A. Rawstron ; R. Tooze [Royaume-Uni] ; A. Cherukuri ; A. Varghese ; E. Vital [Royaume-Uni] ; P. Emery [Royaume-Uni] ; D. Mcgonagle [Royaume-Uni]	THU0088 Abnormal memory B-cell reconstitution following anti-CD20 therapy for autoimmune diseases predicts clinical relapse
002A92 (2013)	S. M. Rashad [Égypte] ; Hassan Bassioni [Égypte] ; Ismail Mohamed [Égypte] ; Abdelaziz Hussein [Égypte] ; Moshrif Abdulhafeez [Égypte]	SAT0525 A Comparison of Magnetic Resonance Imaging, Ultrasonography and Conventional Radiography in Rheumatoid Arthritis of Wrist Joint
002A93 (2013)	S.-Y. Kawashiri ; T. Suzuki ; Y. Nakashima ; Y. Horai ; A. Okada ; N. Iwamoto ; K. Ichinose ; M. Tamai ; K. Arima ; H. Nakamura ; T. Origuchi ; M. Uetani ; K. Aoyagi ; K. Eguchi [Japon] ; A. Kawakami	SAT0524 Automated Breast Volume Scanner (ABVS), a New Automated Ultrasonic Device, is Useful to Examine Joint Injury in Patients with Rheumatoid Arthritis
002B42 (2013)	S. Skacelova ; K. Pavelka ; K. Chroust [République tchèque]	SAT0153 Early response to infliximab therapy predicts long-term disease activity outcomes in patients with rheumatoid arthritis: Results from the czech national biological therapy registry (ATTRA)
002B52 (2013)	T. Kojima [Japon] ; N. Takahashi [Japon] ; K. Funahashi [Japon] ; D. Kato [Japon] ; Y. Hattori [Japon] ; M. Hanabayashi [Japon] ; N. Asai [Japon] ; N. Ishiguro [Japon]	SAT0139 Importance of Concomitant MTX Use During Treatment with Tocilizumab in Patients with Rheumatoid Arthritis

---

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/TocilizumabV1/Data/Main/Exploration

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Teeft.i -k "Eular" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Teeft.i  \
                -Sk "Eular" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    TocilizumabV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    Teeft.i
   |clé=    Eular
}}

---

This area was generated with Dilib version V0.6.34. Data generation: Fri May 22 09:34:00 2020. Site generation: Sun Mar 28 09:01:19 2021